Literature DB >> 12414538

An ethyl-nitrosourea-induced point mutation in phex causes exon skipping, x-linked hypophosphatemia, and rickets.

Marina R Carpinelli1, Ian P Wicks, Natalie A Sims, Kristy O'Donnell, Katherine Hanzinikolas, Rachel Burt, Simon J Foote, Melanie Bahlo, Warren S Alexander, Douglas J Hilton.   

Abstract

We describe the clinical, genetic, biochemical, and molecular characterization of a mouse that arose in the first generation (G(1)) of a random mutagenesis screen with the chemical mutagen ethyl-nitrosourea. The mouse was observed to have skeletal abnormalities inherited with an X-linked dominant pattern of inheritance. The causative mutation, named Skeletal abnormality 1 (Ska1), was shown to be a single base pair mutation in a splice donor site immediately following exon 8 of the Phex (phosphate-regulating gene with homologies to endopeptidases located on the X-chromosome) gene. This point mutation caused skipping of exon 8 from Phex mRNA, hypophosphatemia, and features of rickets. This experimentally induced phenotype mirrors the human condition X-linked hypophosphatemia; directly confirms the role of Phex in phosphate homeostasis, normal skeletal development, and rickets; and illustrates the power of mutagenesis in exploring animal models of human disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12414538      PMCID: PMC1850771          DOI: 10.1016/S0002-9440(10)64468-9

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  24 in total

1.  Non-random distribution of mutations in the PHEX gene, and under-detected missense mutations at non-conserved residues.

Authors:  D Filisetti; G Ostermann; M von Bredow; T Strom; G Filler; J Ehrich; S Pannetier; J M Garnier; P Rowe; F Francis; A Julienne; A Hanauer; M J Econs; C Oudet
Journal:  Eur J Hum Genet       Date:  1999-07       Impact factor: 4.246

Review 2.  Hypophosphatemic rickets.

Authors:  L A DiMeglio; M J Econs
Journal:  Rev Endocr Metab Disord       Date:  2001-04       Impact factor: 6.514

3.  Developmental expression and tissue distribution of Phex protein: effect of the Hyp mutation and relationship to bone markers.

Authors:  A F Ruchon; H S Tenenhouse; M Marcinkiewicz; G Siegfried; J E Aubin; L DesGroseillers; P Crine; G Boileau
Journal:  J Bone Miner Res       Date:  2000-08       Impact factor: 6.741

4.  FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate.

Authors:  A E Bowe; R Finnegan; S M Jan de Beur; J Cho; M A Levine; R Kumar; S C Schiavi
Journal:  Biochem Biophys Res Commun       Date:  2001-06-22       Impact factor: 3.575

5.  The Gy mutation: another cause of X-linked hypophosphatemia in mouse.

Authors:  M F Lyon; C R Scriver; L R Baker; H S Tenenhouse; J Kronick; S Mandla
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

6.  Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia.

Authors:  T Shimada; S Mizutani; T Muto; T Yoneya; R Hino; S Takeda; Y Takeuchi; T Fujita; S Fukumoto; T Yamashita
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

7.  Stimulation of cortical bone mineralization and remodeling by phosphate and 1,25-dihydroxyvitamin D in vitamin D-resistant rickets.

Authors:  P J Marie; F H Glorieux
Journal:  Metab Bone Dis Relat Res       Date:  1981

8.  Ethylnitrosourea mutagenesis and the isolation of mutant alleles for specific genes located in the T region of mouse chromosome 17.

Authors:  V C Bode
Journal:  Genetics       Date:  1984-10       Impact factor: 4.562

9.  Osteomalacia in hereditary hypophosphatemic rickets with hypercalciuria: a correlative clinical-histomorphometric study.

Authors:  D Gazit; M Tieder; U A Liberman; L Passi-Even; I A Bab
Journal:  J Clin Endocrinol Metab       Date:  1991-01       Impact factor: 5.958

10.  Renal Na(+)-phosphate cotransport in murine X-linked hypophosphatemic rickets. Molecular characterization.

Authors:  H S Tenenhouse; A Werner; J Biber; S Ma; J Martel; S Roy; H Murer
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

View more
  10 in total

1.  A Phex mutation in a murine model of X-linked hypophosphatemia alters phosphate responsiveness of bone cells.

Authors:  Shoji Ichikawa; Anthony M Austin; Amie K Gray; Michael J Econs
Journal:  J Bone Miner Res       Date:  2012-02       Impact factor: 6.741

2.  Role of matrix extracellular phosphoglycoprotein in the pathogenesis of X-linked hypophosphatemia.

Authors:  Shiguang Liu; Thomas A Brown; Jianping Zhou; Zhou-Sheng Xiao; Hani Awad; Farshid Guilak; L Darryl Quarles
Journal:  J Am Soc Nephrol       Date:  2005-04-20       Impact factor: 10.121

3.  Dosage effect of a Phex mutation in a murine model of X-linked hypophosphatemia.

Authors:  Shoji Ichikawa; Amie K Gray; Emmanuel Bikorimana; Michael J Econs
Journal:  Calcif Tissue Int       Date:  2013-05-23       Impact factor: 4.333

4.  New intragenic deletions in the Phex gene clarify X-linked hypophosphatemia-related abnormalities in mice.

Authors:  Bettina Lorenz-Depiereux; Victoria E Guido; Kenneth R Johnson; Qing Yin Zheng; Leona H Gagnon; Joiel D Bauschatz; Muriel T Davisson; Linda L Washburn; Leah Rae Donahue; Tim M Strom; Eva M Eicher
Journal:  Mamm Genome       Date:  2004-03       Impact factor: 2.957

5.  New mouse models for metabolic bone diseases generated by genome-wide ENU mutagenesis.

Authors:  Sibylle Sabrautzki; Isabel Rubio-Aliaga; Wolfgang Hans; Helmut Fuchs; Birgit Rathkolb; Julia Calzada-Wack; Christian M Cohrs; Matthias Klaften; Hartwig Seedorf; Sebastian Eck; Ana Benet-Pagès; Jack Favor; Irene Esposito; Tim M Strom; Eckhard Wolf; Bettina Lorenz-Depiereux; Martin Hrabě de Angelis
Journal:  Mamm Genome       Date:  2012-04-21       Impact factor: 2.957

6.  Kbus/Idr, a mutant mouse strain with skeletal abnormalities and hypophosphatemia: identification as an allele of 'Hyp'.

Authors:  Kenji Moriyama; Atsuko Hanai; Kazuyuki Mekada; Atsushi Yoshiki; Katsueki Ogiwara; Atsushi Kimura; Takayuki Takahashi
Journal:  J Biomed Sci       Date:  2011-08-20       Impact factor: 8.410

Review 7.  FGF23 and its role in X-linked hypophosphatemia-related morbidity.

Authors:  Signe Sparre Beck-Nielsen; Zulf Mughal; Dieter Haffner; Ola Nilsson; Elena Levtchenko; Gema Ariceta; Carmen de Lucas Collantes; Dirk Schnabel; Ravi Jandhyala; Outi Mäkitie
Journal:  Orphanet J Rare Dis       Date:  2019-02-26       Impact factor: 4.123

8.  Novel PHEX gene locus-specific database: Comprehensive characterization of vast number of variants associated with X-linked hypophosphatemia (XLH).

Authors:  Soodabeh Sarafrazi; Sean C Daugherty; Nicole Miller; Patrick Boada; Thomas O Carpenter; Lauren Chunn; Kariena Dill; Michael J Econs; Scott Eisenbeis; Erik A Imel; Britt Johnson; Mark J Kiel; Stan Krolczyk; Prameela Ramesan; Rebecca Truty; Yves Sabbagh
Journal:  Hum Mutat       Date:  2021-12-05       Impact factor: 4.700

9.  PHEXL222P Mutation Increases Phex Expression in a New ENU Mouse Model for XLH Disease.

Authors:  Carole El Hakam; Alexis Parenté; Fabienne Baraige; Laetitia Magnol; Lionel Forestier; Florent Di Meo; Véronique Blanquet
Journal:  Genes (Basel)       Date:  2022-07-28       Impact factor: 4.141

10.  N-ethyl-N-nitrosourea mutagenesis produced a small number of mice with altered plasma electrolyte levels.

Authors:  Bernhard Aigner; Birgit Rathkolb; Martina Klempt; Sibylle Wagner; Dian Michel; Martin Hrabé de Angelis; Eckhard Wolf
Journal:  J Biomed Sci       Date:  2009-06-08       Impact factor: 8.410

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.